 | • レポートコード：QYR2104Z0996 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、乳がん治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、生物学的標的療法、乳腺手術、ホルモン療法）、用途別市場規模（病院、クリニック、外来診療ユニット）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・乳がん治療の市場動向 ・企業の競争状況、市場シェア ・乳がん治療の種類別市場規模（化学療法、放射線療法、生物学的標的療法、乳腺手術、ホルモン療法） ・乳がん治療の用途別市場規模（病院、クリニック、外来診療ユニット） ・乳がん治療の北米市場規模2016-2027（アメリカ、カナダ） ・乳がん治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・乳がん治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・乳がん治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・乳がん治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（F. Hoffmann-La Roche、Novartis、Merck、Eli Lilly and Company、Johnson & Johnson、Pfizer、AstraZeneca、GlaxoSmithKline、Sun Pharmaceutical Industries、Bayer、Gilead Sciences） ・結論 |
Breast cancer is the one of the most prevalent cancer and among the leading cause of death in cancer patients. According, to WHO 2013 report 50800 women died of breast cancer in 2011. Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast cancer. Although cancer has spread to other parts of the body, but it is treated as breast cancer only. Usually, metastatic breast cancer occurs months or years after completion of treatment for early or locally advanced stages of breast cancer. Metastatic breast cancer cannot be cured. As it has spread to other organs, so it becomes impossible to get rid of all types of cancer. But the treatment of metastatic breast cancer can extend patient’s life with increasing quality of life. Treatment of metastatic breast cancer is influenced by factors such as symptoms, past treatments, cancer cell characteristics and organs affected.
Metastatic breast cancer treatment market is estimated to be driven by the increasing prevalence of breast cancer and its recurrence. Development of new technologies and increasing awareness among people is expected to drive demand for metastatic breast cancer treatment. Unavailability of effective treatment to cure and side effects related to the treatment can restrict the growth of metastatic breast cancer treatment market. High cost associated with the metastatic breast cancer treatment can also hinder the growth of this market.
Market Analysis and Insights: Global Breast Cancer Treatment Market
The global Breast Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Breast Cancer Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Breast Cancer Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Breast Cancer Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Breast Cancer Treatment market.
Global Breast Cancer Treatment Scope and Market Size
Breast Cancer Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Breast Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Chemotherapy
Radiation Therapy
Biologic Targeted Therapy
Breast Surgery
Hormone Therapy
Segment by Application
Hospitals
Clinics
Ambulatory Care Units
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
F. Hoffmann-La Roche
Novartis
Merck
Eli Lilly and Company
Johnson & Johnson
Pfizer
AstraZeneca
GlaxoSmithKline
Sun Pharmaceutical Industries
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Breast Cancer Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Radiation Therapy
1.2.4 Biologic Targeted Therapy
1.2.5 Breast Surgery
1.2.6 Hormone Therapy
1.3 Market by Application
1.3.1 Global Breast Cancer Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Care Units
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Breast Cancer Treatment Market Perspective (2016-2027)
2.2 Breast Cancer Treatment Growth Trends by Regions
2.2.1 Breast Cancer Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Breast Cancer Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Breast Cancer Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Breast Cancer Treatment Industry Dynamic
2.3.1 Breast Cancer Treatment Market Trends
2.3.2 Breast Cancer Treatment Market Drivers
2.3.3 Breast Cancer Treatment Market Challenges
2.3.4 Breast Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Breast Cancer Treatment Players by Revenue
3.1.1 Global Top Breast Cancer Treatment Players by Revenue (2016-2021)
3.1.2 Global Breast Cancer Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Breast Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Breast Cancer Treatment Revenue
3.4 Global Breast Cancer Treatment Market Concentration Ratio
3.4.1 Global Breast Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Breast Cancer Treatment Revenue in 2020
3.5 Breast Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Breast Cancer Treatment Product Solution and Service
3.7 Date of Enter into Breast Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Breast Cancer Treatment Breakdown Data by Type
4.1 Global Breast Cancer Treatment Historic Market Size by Type (2016-2021)
4.2 Global Breast Cancer Treatment Forecasted Market Size by Type (2022-2027)
5 Breast Cancer Treatment Breakdown Data by Application
5.1 Global Breast Cancer Treatment Historic Market Size by Application (2016-2021)
5.2 Global Breast Cancer Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Breast Cancer Treatment Market Size (2016-2027)
6.2 North America Breast Cancer Treatment Market Size by Type
6.2.1 North America Breast Cancer Treatment Market Size by Type (2016-2021)
6.2.2 North America Breast Cancer Treatment Market Size by Type (2022-2027)
6.2.3 North America Breast Cancer Treatment Market Size by Type (2016-2027)
6.3 North America Breast Cancer Treatment Market Size by Application
6.3.1 North America Breast Cancer Treatment Market Size by Application (2016-2021)
6.3.2 North America Breast Cancer Treatment Market Size by Application (2022-2027)
6.3.3 North America Breast Cancer Treatment Market Size by Application (2016-2027)
6.4 North America Breast Cancer Treatment Market Size by Country
6.4.1 North America Breast Cancer Treatment Market Size by Country (2016-2021)
6.4.2 North America Breast Cancer Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Breast Cancer Treatment Market Size (2016-2027)
7.2 Europe Breast Cancer Treatment Market Size by Type
7.2.1 Europe Breast Cancer Treatment Market Size by Type (2016-2021)
7.2.2 Europe Breast Cancer Treatment Market Size by Type (2022-2027)
7.2.3 Europe Breast Cancer Treatment Market Size by Type (2016-2027)
7.3 Europe Breast Cancer Treatment Market Size by Application
7.3.1 Europe Breast Cancer Treatment Market Size by Application (2016-2021)
7.3.2 Europe Breast Cancer Treatment Market Size by Application (2022-2027)
7.3.3 Europe Breast Cancer Treatment Market Size by Application (2016-2027)
7.4 Europe Breast Cancer Treatment Market Size by Country
7.4.1 Europe Breast Cancer Treatment Market Size by Country (2016-2021)
7.4.2 Europe Breast Cancer Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Breast Cancer Treatment Market Size (2016-2027)
8.2 Asia-Pacific Breast Cancer Treatment Market Size by Type
8.2.1 Asia-Pacific Breast Cancer Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Breast Cancer Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Breast Cancer Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Breast Cancer Treatment Market Size by Application
8.3.1 Asia-Pacific Breast Cancer Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Breast Cancer Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Breast Cancer Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Breast Cancer Treatment Market Size by Region
8.4.1 Asia-Pacific Breast Cancer Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Breast Cancer Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Breast Cancer Treatment Market Size (2016-2027)
9.2 Latin America Breast Cancer Treatment Market Size by Type
9.2.1 Latin America Breast Cancer Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Breast Cancer Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Breast Cancer Treatment Market Size by Type (2016-2027)
9.3 Latin America Breast Cancer Treatment Market Size by Application
9.3.1 Latin America Breast Cancer Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Breast Cancer Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Breast Cancer Treatment Market Size by Application (2016-2027)
9.4 Latin America Breast Cancer Treatment Market Size by Country
9.4.1 Latin America Breast Cancer Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Breast Cancer Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Breast Cancer Treatment Market Size (2016-2027)
10.2 Middle East & Africa Breast Cancer Treatment Market Size by Type
10.2.1 Middle East & Africa Breast Cancer Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Breast Cancer Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Breast Cancer Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Breast Cancer Treatment Market Size by Application
10.3.1 Middle East & Africa Breast Cancer Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Breast Cancer Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Breast Cancer Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Breast Cancer Treatment Market Size by Country
10.4.1 Middle East & Africa Breast Cancer Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Breast Cancer Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Details
11.1.2 F. Hoffmann-La Roche Business Overview
11.1.3 F. Hoffmann-La Roche Breast Cancer Treatment Introduction
11.1.4 F. Hoffmann-La Roche Revenue in Breast Cancer Treatment Business (2016-2021)
11.1.5 F. Hoffmann-La Roche Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Breast Cancer Treatment Introduction
11.2.4 Novartis Revenue in Breast Cancer Treatment Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Breast Cancer Treatment Introduction
11.3.4 Merck Revenue in Breast Cancer Treatment Business (2016-2021)
11.3.5 Merck Recent Development
11.4 Eli Lilly and Company
11.4.1 Eli Lilly and Company Company Details
11.4.2 Eli Lilly and Company Business Overview
11.4.3 Eli Lilly and Company Breast Cancer Treatment Introduction
11.4.4 Eli Lilly and Company Revenue in Breast Cancer Treatment Business (2016-2021)
11.4.5 Eli Lilly and Company Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Breast Cancer Treatment Introduction
11.5.4 Johnson & Johnson Revenue in Breast Cancer Treatment Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Breast Cancer Treatment Introduction
11.6.4 Pfizer Revenue in Breast Cancer Treatment Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Breast Cancer Treatment Introduction
11.7.4 AstraZeneca Revenue in Breast Cancer Treatment Business (2016-2021)
11.7.5 AstraZeneca Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Breast Cancer Treatment Introduction
11.8.4 GlaxoSmithKline Revenue in Breast Cancer Treatment Business (2016-2021)
11.8.5 GlaxoSmithKline Recent Development
11.9 Sun Pharmaceutical Industries
11.9.1 Sun Pharmaceutical Industries Company Details
11.9.2 Sun Pharmaceutical Industries Business Overview
11.9.3 Sun Pharmaceutical Industries Breast Cancer Treatment Introduction
11.9.4 Sun Pharmaceutical Industries Revenue in Breast Cancer Treatment Business (2016-2021)
11.9.5 Sun Pharmaceutical Industries Recent Development
11.10 Bayer
11.10.1 Bayer Company Details
11.10.2 Bayer Business Overview
11.10.3 Bayer Breast Cancer Treatment Introduction
11.10.4 Bayer Revenue in Breast Cancer Treatment Business (2016-2021)
11.10.5 Bayer Recent Development
11.11 Gilead Sciences
11.11.1 Gilead Sciences Company Details
11.11.2 Gilead Sciences Business Overview
11.11.3 Gilead Sciences Breast Cancer Treatment Introduction
11.11.4 Gilead Sciences Revenue in Breast Cancer Treatment Business (2016-2021)
11.11.5 Gilead Sciences Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Breast Cancer Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Radiation Therapy
Table 4. Key Players of Biologic Targeted Therapy
Table 5. Key Players of Breast Surgery
Table 6. Key Players of Hormone Therapy
Table 7. Global Breast Cancer Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Breast Cancer Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Breast Cancer Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Breast Cancer Treatment Market Share by Regions (2016-2021)
Table 11. Global Breast Cancer Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Breast Cancer Treatment Market Share by Regions (2022-2027)
Table 13. Breast Cancer Treatment Market Trends
Table 14. Breast Cancer Treatment Market Drivers
Table 15. Breast Cancer Treatment Market Challenges
Table 16. Breast Cancer Treatment Market Restraints
Table 17. Global Breast Cancer Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Breast Cancer Treatment Market Share by Players (2016-2021)
Table 19. Global Top Breast Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breast Cancer Treatment as of 2020)
Table 20. Ranking of Global Top Breast Cancer Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Breast Cancer Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Breast Cancer Treatment Product Solution and Service
Table 24. Date of Enter into Breast Cancer Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Breast Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Breast Cancer Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Breast Cancer Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Breast Cancer Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Breast Cancer Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Breast Cancer Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Breast Cancer Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Breast Cancer Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Breast Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Breast Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Breast Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Breast Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Breast Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Breast Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Breast Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Breast Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Breast Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Breast Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Breast Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Breast Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Breast Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Breast Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Breast Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Breast Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Breast Cancer Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Breast Cancer Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Breast Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Breast Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Breast Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Breast Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Breast Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Breast Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Breast Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Breast Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Breast Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Breast Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Breast Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Breast Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. F. Hoffmann-La Roche Company Details
Table 65. F. Hoffmann-La Roche Business Overview
Table 66. F. Hoffmann-La Roche Breast Cancer Treatment Product
Table 67. F. Hoffmann-La Roche Revenue in Breast Cancer Treatment Business (2016-2021) & (US$ Million)
Table 68. F. Hoffmann-La Roche Recent Development
Table 69. Novartis Company Details
Table 70. Novartis Business Overview
Table 71. Novartis Breast Cancer Treatment Product
Table 72. Novartis Revenue in Breast Cancer Treatment Business (2016-2021) & (US$ Million)
Table 73. Novartis Recent Development
Table 74. Merck Company Details
Table 75. Merck Business Overview
Table 76. Merck Breast Cancer Treatment Product
Table 77. Merck Revenue in Breast Cancer Treatment Business (2016-2021) & (US$ Million)
Table 78. Merck Recent Development
Table 79. Eli Lilly and Company Company Details
Table 80. Eli Lilly and Company Business Overview
Table 81. Eli Lilly and Company Breast Cancer Treatment Product
Table 82. Eli Lilly and Company Revenue in Breast Cancer Treatment Business (2016-2021) & (US$ Million)
Table 83. Eli Lilly and Company Recent Development
Table 84. Johnson & Johnson Company Details
Table 85. Johnson & Johnson Business Overview
Table 86. Johnson & Johnson Breast Cancer Treatment Product
Table 87. Johnson & Johnson Revenue in Breast Cancer Treatment Business (2016-2021) & (US$ Million)
Table 88. Johnson & Johnson Recent Development
Table 89. Pfizer Company Details
Table 90. Pfizer Business Overview
Table 91. Pfizer Breast Cancer Treatment Product
Table 92. Pfizer Revenue in Breast Cancer Treatment Business (2016-2021) & (US$ Million)
Table 93. Pfizer Recent Development
Table 94. AstraZeneca Company Details
Table 95. AstraZeneca Business Overview
Table 96. AstraZeneca Breast Cancer Treatment Product
Table 97. AstraZeneca Revenue in Breast Cancer Treatment Business (2016-2021) & (US$ Million)
Table 98. AstraZeneca Recent Development
Table 99. GlaxoSmithKline Company Details
Table 100. GlaxoSmithKline Business Overview
Table 101. GlaxoSmithKline Revenue in Breast Cancer Treatment Business (2016-2021) & (US$ Million)
Table 102. GlaxoSmithKline Recent Development
Table 103. Sun Pharmaceutical Industries Company Details
Table 104. Sun Pharmaceutical Industries Business Overview
Table 105. Sun Pharmaceutical Industries Breast Cancer Treatment Product
Table 106. Sun Pharmaceutical Industries Revenue in Breast Cancer Treatment Business (2016-2021) & (US$ Million)
Table 107. Sun Pharmaceutical Industries Recent Development
Table 108. Bayer Company Details
Table 109. Bayer Business Overview
Table 110. Bayer Breast Cancer Treatment Product
Table 111. Bayer Revenue in Breast Cancer Treatment Business (2016-2021) & (US$ Million)
Table 112. Bayer Recent Development
Table 113. Gilead Sciences Company Details
Table 114. Gilead Sciences Business Overview
Table 115. Gilead Sciences Breast Cancer Treatment Product
Table 116. Gilead Sciences Revenue in Breast Cancer Treatment Business (2016-2021) & (US$ Million)
Table 117. Gilead Sciences Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Breast Cancer Treatment Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Radiation Therapy Features
Figure 4. Biologic Targeted Therapy Features
Figure 5. Breast Surgery Features
Figure 6. Hormone Therapy Features
Figure 7. Global Breast Cancer Treatment Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Ambulatory Care Units Case Studies
Figure 11. Breast Cancer Treatment Report Years Considered
Figure 12. Global Breast Cancer Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Breast Cancer Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Breast Cancer Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Breast Cancer Treatment Market Share by Regions (2022-2027)
Figure 16. Global Breast Cancer Treatment Market Share by Players in 2020
Figure 17. Global Top Breast Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breast Cancer Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Breast Cancer Treatment Revenue in 2020
Figure 19. Global Breast Cancer Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Breast Cancer Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Breast Cancer Treatment Market Share by Type (2016-2027)
Figure 23. North America Breast Cancer Treatment Market Share by Application (2016-2027)
Figure 24. North America Breast Cancer Treatment Market Share by Country (2016-2027)
Figure 25. United States Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Breast Cancer Treatment Market Share by Type (2016-2027)
Figure 29. Europe Breast Cancer Treatment Market Share by Application (2016-2027)
Figure 30. Europe Breast Cancer Treatment Market Share by Country (2016-2027)
Figure 31. Germany Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Breast Cancer Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Breast Cancer Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Breast Cancer Treatment Market Share by Region (2016-2027)
Figure 41. China Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Breast Cancer Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Breast Cancer Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Breast Cancer Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Breast Cancer Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Breast Cancer Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Breast Cancer Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Breast Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. F. Hoffmann-La Roche Revenue Growth Rate in Breast Cancer Treatment Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Breast Cancer Treatment Business (2016-2021)
Figure 62. Merck Revenue Growth Rate in Breast Cancer Treatment Business (2016-2021)
Figure 63. Eli Lilly and Company Revenue Growth Rate in Breast Cancer Treatment Business (2016-2021)
Figure 64. Johnson & Johnson Revenue Growth Rate in Breast Cancer Treatment Business (2016-2021)
Figure 65. Pfizer Revenue Growth Rate in Breast Cancer Treatment Business (2016-2021)
Figure 66. AstraZeneca Revenue Growth Rate in Breast Cancer Treatment Business (2016-2021)
Figure 67. GlaxoSmithKline Revenue Growth Rate in Breast Cancer Treatment Business (2016-2021)
Figure 68. Sun Pharmaceutical Industries Revenue Growth Rate in Breast Cancer Treatment Business (2016-2021)
Figure 69. Bayer Revenue Growth Rate in Breast Cancer Treatment Business (2016-2021)
Figure 70. Gilead Sciences Revenue Growth Rate in Breast Cancer Treatment Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
世界の転移性乳がん治療市場 2021：企業別、地域別、種類・用途別 The Metastatic Breast Cancer Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…- 世界のHER2陰性乳がん治療市場規模・現状・予測（2021年-2027年） HER2 (human epidermal growth factor receptor 2) is a protein that appears on the surface of some breast cancer cells. It may also be called HER2/neu or ErbB2.HER2-negative breast cancer means that the people have little or no HER2 protein. Market Analysis and Insights: Global HER2-negative breast ca…
- 世界のHER2陰性乳がん治療市場規模・現状・予測（2021年-2027年） HER2 (human epidermal growth factor receptor 2) is a protein that appears on the surface of some breast cancer cells. It may also be called HER2/neu or ErbB2.HER2-negative breast cancer means that the people have little or no HER2 protein. Market Analysis and Insights: Global HER2-negative breast ca…
- 世界のトリプルネガティブ乳がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Triple-Negative Breast Cancer Treatment Market The global Triple-Negative Breast Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis…
- 世界の乳がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Breast Cancer Therapeutic Market The global Breast Cancer Therapeutic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, th…